BioTech Holding. dk ApS: Financial statements 2017
CVR: 38241672
Source: annual report 2017, Danish Business Authority
01/12/2016 – 31/12/2017
BioTech Holding. dk ApS (CVR 38241672) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2017 report amounted to DKK 100. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 100
- Total Assets
- DKK 100
Official annual report
Keep an eye on BioTech Holding. dk ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 12, 2017, Jens Christian Larsen is registered as director of BioTech Holding. dk ApS.
As of October 12, 2017, Jørgen Fredebo Jørgensen has stepped down as adm. dir. of BioTech Holding. dk ApS.
On February 23, 2017, the company changed its name from SymbiCom Innovation IVS to SymbiCom Holding IVS.
About BioTech Holding. dk ApS
BioTech Holding. dk ApS was a Danish company of the type Anpartsselskab based in Nykøbing Sj, founded in 2016. The company has been dissolved on 21 January 2026. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named BioTech Holding. dk IVS and SymbiCom Holding IVS. In 2021, the company reported a gross profit of DKK -2,045 and a net result of DKK -4,029 compared with DKK 0 the year before. Equity in the 2021 report amounted to DKK 35,971.